Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was another busy week for Australia's top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:

A financial expert or broker looks worried as he checks out a graph showing market volatility.

Image source: Getty Images

CSL Ltd (ASX: CSL)

According to a note out of Citi, its analysts have retained their buy rating on this biotherapeutics company's shares with an improved price target of $345.00. This follows the release of the company's full year results for FY 2024. Citi was pleased with the result but a little disappointed with CSL's guidance for FY 2025, which was softer than expected. This is due to a slower improvement in the gross margins of the key CSL Behring business. However, with management sticking with its margin targets for the business, Citi remains positive on the future and continues to forecast solid profit growth for the coming years. As a result, it continues to see plenty of value in its shares at current levels. The CSL share price ended the week at $305.34.

Life360 Inc (ASX: 360)

A note out of Bell Potter reveals that its analysts have retained their buy rating on this location technology company's shares with an improved price target of $20.50. This follows the release of the Life360 app maker's second quarter update, which was comfortably ahead of expectations. Bell Potter was particularly happy with the key metrics of total paying circles, AMR, and ARPPC, which were all ahead of its forecasts. However, the highlight for the broker was its record quarter for growth in paying circles of 132,000. And with the seasonally stronger third and fourth quarters to come, Bell Potter is feeling very positive about its outlook. The Life360 share price was fetching $17.97 at Friday's close.

Pilbara Minerals Ltd (ASX: PLS)

Analysts at Morgans have retained their add rating and $3.40 price target on this lithium miner's shares. This follows an announcement last week which revealed that the company has signed an agreement to acquire Latin Resources Ltd (ASX: LRS) through an all-scrip deal. Morgans points out that the market doesn't appear pleased with the deal due to the weak lithium environment. However, it sees positives and notes that the counter-cyclical acquisition could deliver strong results in the future if the miner successfully develops Latin Resources' hard-rock Salinas Lithium Project in Minas Gerais, Brazil. The Pilbara Minerals share price ended the week at $2.90.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in CSL and Life360. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Life360. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans says hold BHP shares and buy this ASX 200 stock      

Let's see what the broker is saying about these stocks this week.

Read more »

An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements
Broker Notes

3 ASX 200 shares just upgraded to strong buy — here's what the brokers are saying

Do any of these ASX 200 stocks appeal to you?

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

Buy, hold, sell: Macquarie, Boss Energy, CBA shares

The market looks set to endure a sixth consecutive day in the red.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

Guess which ASX 200 share could rise 90% according to Bell Potter

Let's see what the broker is saying about this stock this week.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

These ASX 200 shares could rise 25% to 70%

Morgans expects big returns from these top stocks.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Broker Notes

Down 42% in a year, are Boss Energy shares now a bargain buy?

A leading analyst provides his outlook for Boss Energy’s beaten down shares.

Read more »